These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 9667972)

  • 1. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
    Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
    J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
    Kim YC; Ji XD; Jacobson KA
    J Med Chem; 1996 Oct; 39(21):4142-8. PubMed ID: 8863790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.
    Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE
    ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
    van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
    Ji XD; Jacobson KA
    Drug Des Discov; 1999 Nov; 16(3):217-26. PubMed ID: 10624567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
    J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.
    Al-Salahi R; Geffken D; Koellner M
    Chem Pharm Bull (Tokyo); 2011; 59(6):730-3. PubMed ID: 21628909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
    Karton Y; Jiang JL; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1996 Jun; 39(12):2293-301. PubMed ID: 8691424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
    Jiang JL; van Rhee AM; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1996 Nov; 39(23):4667-75. PubMed ID: 8917655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
    Palmer TM; Poucher SM; Jacobson KA; Stiles GL
    Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1998 Aug; 41(17):3186-201. PubMed ID: 9703464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.
    Fredholm BB; Irenius E; Kull B; Schulte G
    Biochem Pharmacol; 2001 Feb; 61(4):443-8. PubMed ID: 11226378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    Merighi S; Varani K; Gessi S; Cattabriga E; Iannotta V; Ulouglu C; Leung E; Borea PA
    Br J Pharmacol; 2001 Nov; 134(6):1215-26. PubMed ID: 11704641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
    Jacobson KA; Siddiqi SM; Olah ME; Ji XD; Melman N; Bellamkonda K; Meshulam Y; Stiles GL; Kim HO
    J Med Chem; 1995 May; 38(10):1720-35. PubMed ID: 7752196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.